INMD
Inmode Ltd
NASDAQ · Health Care
$15.08
+0.26 (+1.75%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 309.64M | 299.58M | 449.11M | 462.47M | 410.22M |
| Net Income | 142.17M | 123.79M | 32.27M | 36.91M | 32.85M |
| EPS | — | — | — | — | — |
| Profit Margin | 45.9% | 43.6% | 7.2% | 8.0% | 8.0% |
| Rev Growth | +3.4% | +3.4% | -8.9% | +23.7% | -7.6% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 0 | 0 | 196.83M | 194.47M | 186.33M |
| Total Equity | — | — | 528.24M | 586.74M | 612.01M |
| D/E Ratio | — | — | 0.37 | 0.33 | 0.30 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 88.83M | 81.64M | 76.66M | 80.84M | 68.77M |
| Free Cash Flow | — | — | 38.73M | 41.14M | 42.54M |